ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - phenylbutazone - oral paste - phenylbutazone analgesic active 200.0 mg/ml - musculoskeletal system

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - ceftiofur as ceftiofur sodium - parenteral liquid/solution/suspension - ceftiofur as ceftiofur sodium antibiotic active 50.0 mg/ml - antibiotic & related - cattle | dog | horse | beef | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castrate | colt | co - infections of the respiratory tract | infections of the urinary tracts | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | staphylococcus spp. | tonsillitis

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - detomidine hydrochloride - parenteral liquid/solution/suspension - detomidine hydrochloride imidazole active 10.0 mg/ml - anaesthetics/analgesics - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - analgesic | colic | sedative | antipyretic | colic | muscle relaxant | sedative | spasmolytic

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - deslorelin as deslorelin acetate - parenteral liquid/solution/suspension - deslorelin as deslorelin acetate ungrouped active 1.25 mg/ml - endocrine system

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

s & i cameron t/a trans global industries - evening primrose oil, quantity: 1 g (equivalent: gamma-linolenic acid, qty 100 mg) - capsule, soft - excipient ingredients: d-alpha-tocopherol; soya oil; gelatin; glycerol

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

cameron pharmaceuticals, llc - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - amiodarone hydrochloride is indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. - cardiogenic shock. - sick sinus syndrome, second- or third-degree atrioventricular block, bradycardia leading to syncope without a functioning pacemaker. - known hypersensitivity to the drug or to any of its components, including iodine. risk summary available data from postmarketing reports and published case series indicate that amiodarone use in pregnant women may increase the risk for fetal adverse effects including neonatal hypo- and hyperthyroidism, neonatal bradycardia, neurodevelopmental abnormalities, preterm birth and fetal growth restriction. amiodarone and its metabolite, desethylamiodarone (dea), cross the placenta. untreated underlying arrhythmias, including ventricular arrh

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

cameron pharmaceuticals - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen delayed-release tablets are indicated for: the relief of the signs and symptoms of: - rheumatoid arthritis - osteoarthritis - ankylosing spondylitis - polyarticular juvenile idiopathic arthritis naproxen delayed-release tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see warnings and precautions (5.7, 5.9)] . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)]. - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1)] . risk summary use of nsaids, including naproxen delayed-release tablets can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

shreya - calcium,phosphorus - tab - 66,30;mg;(mchc) - 10

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

health & hygiene - tab - 10

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

health & hygiene - sus - 200ml